IGM Biosciences, Inc.
MULTIMERIC CD40 BINDING MOLECULES AND USES THEREOF

Last updated:

Abstract:

This disclosure provides dimeric, pentameric, and hexameric CD40 agonist binding molecules and methods of using such binding molecules to induce anti-tumor immunity.

Status:
Application
Type:

Utility

Filling date:

17 Dec 2021

Issue date:

7 Apr 2022